FDA Approves Higher-Dose Version of Aflibercept
The FDA approved a higher dosage of aflibercept (Eylea) for the treatment of age-related macular degeneration, macular edema, and diabetic retinopathy.
United States Peter Kaiser Georged Yancopoulos European Union Cleveland Clinic Lerner College Of Medicine Cole Eye Institute
Source: ajmc.com